Antimicrobial resistance in Salmonella in the United States from 1948 to 1995

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 4, 2016, Pages 2567-2571

  Tadesse, Daniel A ^a   Singh, Aparna ^b   Zhao, Shaohua ^a   Bartholomew, Mary ^a   Womack, Niketta ^a,c   Ayers, Sherry ^a   Fields, Patricia I ^c   McDermott, Patrick F ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFALOTIN; CEFOXITIN; CEFTIOFUR; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; STREPTOMYCIN; SULFAMETHOXAZOLE; SULFANILAMIDE; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALMONELLA; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SEROTYPE; UNITED STATES; CLASSIFICATION; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEALTH SURVEY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR EVOLUTION; SALMONELLA INFECTIONS;

AMPICILLIN; ANTI-BACTERIAL AGENTS; CHLORAMPHENICOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EVOLUTION, MOLECULAR; HUMANS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PUBLIC HEALTH SURVEILLANCE; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SEROGROUP; STREPTOMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE; UNITED STATES;

EID: 84963603768     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02536-15     Document Type: Article

References (28)

1. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM. 2011. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis 17:7-15. http://dx.doi.org/10.3201/eid1701. P11101.
2. Travers K, Barza M. 2002. Morbidity of infections caused by antimicrobial-resistant bacteria. Clin Infect Dis 34(Suppl 3):S131-S134.
3. Varma JK, Molbak K, Barrett TJ, Beebe JL, Jones TF, Rabatsky-Ehr T, Smith KE, Vugia DJ, Chang HG, Angulo FJ. 2005. Antimicrobialresistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis 191:554-561. http://dx.doi.org/10.1086/427263.
4. Helms M, Vastrup P, Gerner-Smidt P, Molbak K. 2002. Excess mortality associated with antimicrobial drug-resistant Salmonella Typhimurium. Emerg Infect Dis 8:490-495. http://dx.doi.org/10.3201/eid0805.010267.
5. Hohmann EL. 2001. Nontyphoidal salmonellosis. Clin Infect Dis 32:263-269. http://dx.doi.org/10.1086/318457.
6. Gilbert JM, White DG, McDermott PF. 2007. The US national antimicrobial resistance monitoring system. Future Microbiol 2:493-500. http://dx.doi.org/10.2217/17460913.2.5.493.
7. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. CLSI document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Salmi T, Määttä A, Anttila P, Ruoho-Airola T, Amnell T. 2002. Detecting trends of annual values of atmospheric pollutants by the Mann-Kendall test and Sen's slope estimates: the excel template application MAKESENS. Finnish Meteorological Institute, Helsinki, Finland.
9. Tadesse DA, Zhao S, Tong E, Ayers S, Singh A, Bartholomew MJ, McDermott PF. 2012. Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950-2002. Emerg Infect Dis 18:741-749. http://dx.doi.org/10.3201/eid1805.111153.
10. Bissett ML, Abbott SL, Wood RM. 1974. Antimicrobial resistance and R factors in Salmonella isolated in California (1971-1972). Antimicrob Agents Chemother 5:161-168. http://dx.doi.org/10.1128/AAC.5.2.161.
11. Pocurull DW, Gaines SA, Mercer HD. 1971. Survey of infectious multiple drug resistance among salmonella isolated from animals in the United States. Appl Microbiol 21:358-362.
12. U. S. Food and Drug Administration. 2013. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS):2010 executive report. U. S. Food and Drug Administration, Rockville, MD.
13. Skold O. 2001. Resistance to trimethoprim and sulfonamides. Vet Res 32:261-273. http://dx.doi.org/10.1051/vetres:2001123.
14. Cohen ML, Tauxe RV. 1986. Drug-resistant Salmonella in the United States: an epidemiologic perspective. Science 234:964-969. http://dx.doi.org/10.1126/science.3535069.
15. Smith SM, Palumbo PE, Edelson PJ. 1984. Salmonella strains resistant to multiple antibiotics: therapeutic implications. Pediatr Infect Dis 3:455-460. http://dx.doi.org/10.1097/00006454-198409000-00017.
16. U. S. Food and Drug Administration. 2015. 2013 Summary report on antimicrobials sold or distributed for use in food-producing animals. U. S. Food and Drug Administration, Rockville, MD. Accessed31 January 2016. http://www.fda.gov/downloads/ForIndustry/UserFees/AnimalDrugUser FeeActADUFA/UCM440584.pdf.
17. Enne VI, Livermore DM, Stephens P, Hall LM. 2001. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 357:1325-1328. http://dx.doi.org/10.1016/S0140-6736 (00) 04519-0.
18. Lee LA, Puhr ND, Maloney EK, Bean NH, Tauxe RV. 1994. Increase in antimicrobial-resistant Salmonella infections in the United States, 1989-1990. J Infect Dis 170:128-134. http://dx.doi.org/10.1093/infdis/170.1.128.
19. MacDonald KL, Cohen ML, Hargrett-Bean NT, Wells JG, Puhr ND, Collin SF, Blake PA. 1987. Changes in antimicrobial resistance of Salmonella isolated from humans in the United States. JAMA 258:1496-1499.
20. Centers for Disease Control and Prevention (CDC). 2002. Outbreak of multidrug-resistant Salmonella Newport-United States, January-April 2002. Morbid Mortal Wkly Rep 51:545-548.
21. Gupta A, Fontana J, Crowe C, Bolstorff B, Stout A, Van Duyne S, Hoekstra MP, Whichard JM, Barrett TJ, Angulo FJ. 2003. Emergence of multidrug-resistantSalmonella entericaserotype Newport infections resistant to expanded-spectrum cephalosporins in the United States. J Infect Dis 188:1707-1716. http://dx.doi.org/10.1086/379668.
22. Zhao S, Qaiyumi S, Friedman S, Singh R, Foley SL, White DG, McDermott PF, Donkar T, Bolin C, Munro S, Baron EJ, Walker RD. 2003. Characterization of Salmonella enterica serotype Newport isolated from humans and food animals. J Clin Microbiol 41:5366-5371. http://dx.doi.org/10.1128/JCM.41.12.5366-5371.2003.
23. Glynn MK, Bopp C, Dewitt W, Dabney P, Mokhtar M, Angulo FJ. 1998. Emergence of multidrug-resistant Salmonella enterica serotype Typhimurium DT104 infections in the United States. N Engl JMed 338:1333-1338. http://dx.doi.org/10.1056/NEJM199805073381901.
24. Rabatsky-Ehr T, Whichard J, Rossiter S, Holland B, Stamey K, Headrick ML, Barrett TJ, Angulo FJ. 2004. Multidrug-resistant strains of Salmonella enterica Typhimurium, United States, 1997-1998. Emerg Infect Dis 10:795-801. http://dx.doi.org/10.3201/eid1005.030209.
25. Ribot EM, Wierzba RK, Angulo FJ, Barrett TJ. 2002. Salmonella enterica serotype Typhimurium DT104 isolated from humans, United States, 1985, 1990, and 1995. Emerg Infect Dis 8:387-391. http://dx.doi.org/10.3201/eid0804.010202.
26. Medalla F, Hoekstra RM, Whichard JM, Barzilay EJ, Chiller TM, Joyce K, Rickert R, Krueger A, Stuart A, Griffin PM. 2013. Increase in resistance to ceftriaxone and nonsusceptibility to ciprofloxacin and decrease in multidrug resistance among Salmonella strains, United States, 1996-2009. Foodborne Pathog Dis 10:302-309. http://dx.doi.org/10.1089/fpd.2012.1336.
27. Michael GB, Butaye P, Cloeckaert A, Schwarz S. 2006. Genes and mutations conferring antimicrobial resistance in Salmonella: an update. Microbes Infect 8:1898-1914. http://dx.doi.org/10.1016/j.micinf.2005.12.019.
28. Olsen JE, Brown DJ, Baggesen DL, Bisgaard M. 1994. Stability of plasmids in five strains of Salmonella maintained in stab culture at different temperatures. J Appl Bacteriol 77:155-159. http://dx.doi.org/10.1111/j.1365-2672.1994.tb03059.x.